OBJECTIVE: To evaluate the relationship between the frequency of peripheral CD57+ T cells and the physical status of rheumatoid arthritis (RA) patients, and to perform cytokine analysis of these CD57+ T cells. METHODS: Four-color fluorescence-activated cell sorter analysis was performed to detect both cell surface antigens and intracellular cytokines in peripheral blood leukocytes, using monoclonal antibodies against CD3, CD4, CD8, CD57, interferon-gamma (IFNgamma), and interleukin-4 (IL-4). RA patients were clinically evaluated with a modified Health Assessment Questionnaire (M-HAQ), joint score, face scale, and visual analog scale (VAS) assessing pain and disease activity. RESULTS: There was a significant correlation between the frequency of CD4+,CD57+ T cells and erythrocyte sedimentation rate (ESR), whereas a correlation was not found between the frequency of CD8+,CD57+ T cells and ESR. The frequency of CD4+,CD57+ T cells also showed a significant correlation with the mHAQ score, VAS, and face scale. Again, there was no significant correlation between the above-mentioned clinical scores and the frequency of CD8+,CD57+ T cells. Flow cytometric analysis of intracellular cytokines revealed that 14.5% of the CD57+ T cells produced IFNgamma, whereas only 2.8% of the CD57+ T cells produced IL-4 in RA patients. CONCLUSION: Evidence showing that the frequency of CD4+,CD57+ T cells among CD3+ cells of RA patients had a significant correlation not only with ESR but also with the physical status of the patients, and that a large proportion of the CD4+,CD57+ T cells had the capacity to produce IFNgamma, strongly suggests that these CD4+,CD57+ T cells are involved in the immunopathogenesis of RA.
OBJECTIVE: To evaluate the relationship between the frequency of peripheral CD57+ T cells and the physical status of rheumatoid arthritis (RA) patients, and to perform cytokine analysis of these CD57+ T cells. METHODS: Four-color fluorescence-activated cell sorter analysis was performed to detect both cell surface antigens and intracellular cytokines in peripheral blood leukocytes, using monoclonal antibodies against CD3, CD4, CD8, CD57, interferon-gamma (IFNgamma), and interleukin-4 (IL-4). RApatients were clinically evaluated with a modified Health Assessment Questionnaire (M-HAQ), joint score, face scale, and visual analog scale (VAS) assessing pain and disease activity. RESULTS: There was a significant correlation between the frequency of CD4+,CD57+ T cells and erythrocyte sedimentation rate (ESR), whereas a correlation was not found between the frequency of CD8+,CD57+ T cells and ESR. The frequency of CD4+,CD57+ T cells also showed a significant correlation with the mHAQ score, VAS, and face scale. Again, there was no significant correlation between the above-mentioned clinical scores and the frequency of CD8+,CD57+ T cells. Flow cytometric analysis of intracellular cytokines revealed that 14.5% of the CD57+ T cells produced IFNgamma, whereas only 2.8% of the CD57+ T cells produced IL-4 in RApatients. CONCLUSION: Evidence showing that the frequency of CD4+,CD57+ T cells among CD3+ cells of RApatients had a significant correlation not only with ESR but also with the physical status of the patients, and that a large proportion of the CD4+,CD57+ T cells had the capacity to produce IFNgamma, strongly suggests that these CD4+,CD57+ T cells are involved in the immunopathogenesis of RA.
Authors: Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon Journal: J Clin Immunol Date: 2004-03 Impact factor: 8.317
Authors: Xiaolei Tang; David E Yocum; David Dejonghe; Kathryn Nordensson; Douglas F Lake; John Richard Journal: Immunology Date: 2004-07 Impact factor: 7.397
Authors: Maria C Jiménez-Martínez; Marisela Linares; Renata Báez; Luis F Montaño; Salvador Martínez-Cairo; Patricia Gorocica; Raúl Chávez; Edgar Zenteno; Ricardo Lascurain Journal: Immunology Date: 2004-01 Impact factor: 7.397
Authors: John R Koethe; Wyatt McDonnell; Arion Kennedy; Chike O Abana; Mark Pilkinton; Ian Setliff; Ivelin Georgiev; Louise Barnett; Cindy C Hager; Rita Smith; Spyros A Kalams; Alyssa Hasty; Simon Mallal Journal: J Acquir Immune Defic Syndr Date: 2018-02-01 Impact factor: 3.731
Authors: Ceara E Walsh; Elizabeth J Ryan; Cliona O'Farrelly; Lucy Golden-Mason; Oliver FitzGerald; Douglas J Veale; Barry Bresnihan; Ursula Fearon Journal: PLoS One Date: 2011-11-15 Impact factor: 3.240